Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure

Toxicological Sciences

Volumn 121, Issue 2, 2011, Pages 357-367

  Zimmer, Bastian ^a   Schildknecht, Stefan ^a   Kuegler, Philipp B ^a   Tanavde, Vivek ^b   Kadereit, Suzanne ^a   Leist, Marcel ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b BIOINFORMATICS INSTITUTE   (Singapore)

Author keywords

Chronic; Developmental neurotoxicity; Dopamine; Embryonic stem cells; Metals; Neurotoxicology; Toxicity

Indexed keywords

CEP 1347; DOPAMINE TRANSPORTER; GALANIN RECEPTOR 2; METHYLMERCURY; NEUROTRANSMITTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL LOSS; CELL MATURATION; CELL POPULATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; ENZYME ACTIVITY; MOUSE; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION;

MURINAE;

EID: 79957868414     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfr054     Document Type: Article

References (39)

1. Bencherif, M. (2009). Neuronal nicotinic receptors as novel targets for inflammation and neuroprotection: mechanistic considerations and clinical relevance. cta Pharmacol. Sin. 30, 702-714.
2. Boll, J. B., Geist, M. A., Kaminski Schierle, G. S., Petersen, K., Leist, M., and Vaudano, E. (2004). Improvement of embryonic dopaminergic neurone survival in culture and after grafting into the striatum of hemiparkinsonian rats by CEP-1347. J. Neurochem. 88, 698-707.
3. Burbacher, T. M., Rodier, P. M., and Weiss, B. (1990). Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol. Teratol. 12, 191-202.
4. Calne, D. B., McGeer, E., Eisen, A., and Spencer, P. (1986). Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment? Lancet 328, 1067-1070.
5. Castoldi, A. F., Onishchenko, N., Johansson, C., Coccini, T., Roda, E., Vahter, M., Ceccatelli, S., and Manzo, L. (2008). Neurodevelopmental toxicity of methylmercury: laboratory animal data and their contribution to human risk assessment. Regul. Toxicol. Pharmacol. 51, 215-229.
6. Clarkson, T. W. (1997). The toxicology of mercury. Crit. Rev. Clin. Lab. Sci. 34, 369-403.
7. Dare, E., Fetissov, S., Hokfelt, T., Hall, H., Ogren, S. O., and Ceccatelli, S. (2003). Effects of prenatal exposure to methylmercury on dopaminemediated locomotor activity and dopamine D2 receptor binding. Naunyn. Schmiedebergs. Arch. Pharmacol. 367, 500-508.
8. Di Monte, D. A., Royland, J. E., Irwin, I., and Langston, J. W. (1996). Astrocytes as the site for bioactivation of neurotoxins. Neurotoxicology 17, 697-03.
9. Elliott-Hunt, C. R., Pope, R. J., Vanderplank, P., and Wynick, D. (2007). Activation of the galanin receptor 2 (GalR2) protects the hippocampus from euronal damage. J. Neurochem. 100, 780-789.
10. Fujimura, M., Usuki, F., Sawada, M., and Takashima, A. (2009). Methylmercury induces neuropathological changes with tau hyperphosphorylation mainly through the activation of the c-jun-N-terminal kinase pathway in the cerebral cortex, but not in the hippocampus of the mouse brain. Neurotoxicology 30, 1000-007.
11. Gaspard, N., and Vanderhaeghen, P. (2010). Mechanisms of neural specification from embryonic stem cells. Curr. Opin. Neurobiol. 20, 37-43.
12. Gimenez-Llort, L., Ahlbom, E., Dare, E., Vahter, M., Ogren, S., and Ceccatelli, S. (2001). Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age and gender-dependent effects. Environ. Toxicol. Pharmacol. 9, 61-70.
13. Goulet, S., Dore, F. Y., and Mirault, M. E. (2003). Neurobehavioral changes in mice chronically exposed to methylmercury during fetal and early postnatal evelopment. Neurotoxicol. Teratol. 25, 335-347.
14. Grandjean, P., and Landrigan, P. J. (2006). Developmental neurotoxicity of industrial chemicals. Lancet 368, 2167-2178.
15. Hogberg, H. T., Kinsner-Ovaskainen, A., Coecke, S., Hartung, T., and Bal-Price, A. K. (2010). mRNA expression is a relevant tool to identify developmental neurotoxicants using an in vitro approach. Toxicol. Sci. 113, 95-115.
16. Hogberg, H. T., Kinsner-Ovaskainen, A., Hartung, T., Coecke, S., and Bal-Price, A. K. (2009). Gene expression as a sensitive endpoint to evaluate cell differentiation and maturation of the developing central nervous system in primary cultures of rat cerebellar granule cells (CGCs) exposed to pesticides. Toxicol. Appl. harmacol. 235, 268-286.
17. Johansson, C., Castoldi, A. F., Onishchenko, N., Manzo, L., Vahter, M., and Ceccatelli, S. (2007). Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 11, 241-260.
18. Kuegler, P. B., Zimmer, B., Waldmann, T., Baudis, B., Ilmjarv, S., Hescheler, J., Gaughwin, P., Brundin, P., Mundy, W., Bal-Price, A. K., et al. (2010). Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27, 17-42.
19. Landrigan, P. J., Sonawane, B., Butler, R. N., Trasande, L., Callan, R., and Droller, D. (2005). Early environmental origins of neurodegenerative disease in ater life. Environ. Health Perspect. 113, 1230-1233.
20. Lang, R., Gundlach, A. L., and Kofler, B. (2007). The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health nd disease. Pharmacol. Ther. 115, 177-207.
21. Moors, M., Rockel, T. D., Abel, J., Cline, J. E., Gassmann, K., Schreiber, T., Schuwald, J., Weinmann, N., and Fritsche, E. (2009). Human neurospheres as three-dimensional cellular systems for developmental neurotoxicity testing. Environ. Health Perspect. 117, 1131-1138.
22. Morken, T. S., Sonnewald, U., Aschner, M., and Syversen, T. (2005). Effects of methylmercury on primary brain cells in mono- and co-culture. Toxicol. Sci. 7, 169-175.
23. Newland, M. C., and Rasmussen, E. B. (2000). Aging unmasks adverse effects of gestational exposure to methylmercury in rats. Neurotoxicol. Teratol. 22, 19-828.
24. Ni, M., Li, X., Yin, Z., Jiang, H., Sidoryk-Wegrzynowicz, M., Milatovic, D., Cai, J., and Aschner, M. (2010). Methylmercury induces acute oxidative stress, altering Nrf2 protein level in primary microglial cells. Toxicol. Sci. 116, 590-603.
25. Onishchenko, N., Tamm, C., Vahter, M., Hokfelt, T., Johnson, J. A., Johnson, D. A., and Ceccatelli, S. (2007). Developmental exposure to methylmercury alters learning and induces depression-like behavior in male mice. Toxicol. Sci. 97, 428-437.
26. Paul, G., Christophersen, N. S., Raymon, H., Kiaer, C., Smith, R., and Brundin, P. (2007). Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line-studies in vitro and after intracerebral grafting in vivo. Mol. Cell. Neurosci. 34, 390-399.
27. Radio, N. M., Freudenrich, T. M., Robinette, B. L., Crofton, K. M., and Mundy, W. R. (2010). Comparison of PC12 and cerebellar granule cell cultures for evaluating neurite outgrowth using high content analysis. Neurotoxicol. Teratol. 32, 25-35.
28. Rajanna, B., and Hobson, M. (1985). Influence of mercury on uptake of [3H]dopamine and [3H]norepinephrine by rat brain synaptosomes. Toxicol. Lett. 27, 7-14.
29. Rao, M. S., and Jacobson, M. (2005). In Developmental Neurobiology, 4 ed., p. 413. Kluwer Academic/Plenum Publishers, New York, NY.
30. Reimand, J., Kull, M., Peterson, H., Hansen, J., and Vilo, J. (2007). g:Profiler-a web-based toolset for functional profiling of gene lists from large-scale xperiments. Nucleic Acids Res. 35, W193-W200.
31. Rossi, A. D., Ahlbom, E., Ögren, S. O., Nicotera, P., and Ceccatelli, S. (1997). Prenatal exposure to methylmercury alters locomotor activity of male but not emale rats. Exp. Brain Res. 117, 428-436.
32. Sager, T. N., Kirchhoff, J., Mørk, A., Van Beek, J., Thirstrup, K., Didriksen, M., and Lauridsen, J. B. (2010). Nest building performance following MPTP oxicity in mice. Behav. Brain Res. 208, 444-449.
33. Schildknecht, S., Poltl, D., Nagel, D. M., Matt, F., Scholz, D., Lotharius, J., Schmieg, N., Salvo-Vargas, A., and Leist, M. (2009). Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol. Appl. Pharmacol. 241, 23-35.
34. Slotkin, T. A., Pachman, S., Kavlock, R. J., and Bartolome, J. (1985). Effects of neonatal methylmercury exposure on development of nucleic acids and roteins in rat brain: regional specificity. Brain Res. Bull. 14, 397-400.
35. Tamm, C., Duckworth, J. K., Hermanson, O., and Ceccatelli, S. (2008). Methylmercury inhibits differentiation of rat neural stem cells via Notch signalling. euroreport 19, 339-343.
36. Weiss, B., Clarkson, T. W., and Simon, W. (2002). Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ. Health erspect. 110(Suppl. 5), 851-854.
37. Woods, J. S., and Ellis, M. E. (1995). Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. iochem. Pharmacol. 50, 1719-1724.
38. Ying, Q. L., and Smith, A. G. (2003). Defined conditions for neural commitment and differentiation. Methods Enzymol. 365, 327-341.
39. Zimmer, B., Kuegler, P. B., Baudis, B., Genewsky, A., Tanavde, V., Koh, W., Tan, B., Waldmann, T., Kadereit, S., and Leist, M. (2011). Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basis for novel approaches to developmental neurotoxicity testing. Cell Death iffer. 18, 383-395.